COMMUNIQUÉS West-GlobeNewswire
      -   
  
Nurix Therapeutics Announces $250.0 Million Registered Offering of Common Stock
22/10/2025 -   
  
Appili Therapeutics to Attend BARDA Innovation Symposium 2025
22/10/2025 -   
  
ProPhase Labs Announces Study Validating BE-Smart Esophageal Cancer Test Accepted by Journal of Clinical Gastroenterology and Hepatology
22/10/2025 -   
  
ProMIS Neurosciences Strengthens Board with Appointment of Slanix Paul Alex, Pharm.D., President and Portfolio Manager, Public Equity of Ally Bridge Group
22/10/2025 -   
  
Biogen to Present Additional Results from Phase 3 Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus at ACR Convergence 2025
22/10/2025 -   
  
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer
22/10/2025 -   
  
DataVault AI and Wellgistics Health Announce Plans for PharmacyChain™ to Implement Manufacturer-to-Patient Blockchain-enabled Smart Contracts for the Prescription Drug Industry to Improve Efficiency and Patient Outcomes
22/10/2025 -   
  
Holland Foundation for Sight Restoration Launches Light After Darkness Fundraising Campaign
22/10/2025 -   
  
TerrAscend Reschedules November 6th Third Quarter 2025 Earnings Conference Call to Pre-Open from Post-Market Close
22/10/2025 -   
  
Calidi Biotherapeutics Announces Establishment of Scientific Advisory Board to Support Development of CLD-401 and Advance its RedTail Platform for the Systemic Delivery of Targeted Genetic Medicine
22/10/2025 -   
  
LifeMD Names Dr. Tara Scott as Ambassador and Clinical Advisor for its Women’s Health Program
22/10/2025 -   
  
Collegium Announces Poster Presentations at the American Academy of Child & Adolescent Psychiatry and Neuroscience Education Institute Conferences
22/10/2025 -   
  
Aardvark Therapeutics to Present Data on Pipeline Programs at Upcoming ObesityWeek
22/10/2025 -   
  
R1 Launches Phare, Healthcare’s First Revenue Operating System
22/10/2025 -   
  
DLH Demonstrates Cybersecurity Excellence with CMMC Level 2 Certification
22/10/2025 -   
  
Alignment Health Plan Named a 2026 Best Insurance Company for Medicare Advantage Across All Its Markets by U.S. News & World Report
22/10/2025 -   
  
Synergy CHC (NASDAQ: SNYR) Deepens FOCUSfactor® Expansion with Kroger, PriceSmart & Wakefern — Strengthening U.S., Canada, and Global Reach
22/10/2025 -   
  
Noah Medical Expands Clinical Evidence for the Galaxy System With Two New Studies Presented at CHEST 2025
22/10/2025 -   
  
CytoMed Therapeutics’ Chairman Increases Effective Holdings to 21.95%
22/10/2025 
Pages